Synthomer PLC (SYNT) Receives Average Rating of “Hold” from Analysts
Shares of Synthomer PLC (LON:SYNT) have been assigned an average recommendation of “Hold” from the thirteen brokerages that are currently covering the company, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a sell recommendation, three have given a hold recommendation and seven have given a buy recommendation to the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is GBX 487.75 ($6.61).
A number of research analysts have commented on the stock. Canaccord Genuity raised their price target on shares of Synthomer from GBX 525 ($7.12) to GBX 575 ($7.80) and gave the stock a “buy” rating in a research note on Friday, January 5th. Deutsche Bank restated a “buy” rating and set a GBX 565 ($7.66) price target on shares of Synthomer in a research note on Thursday, January 4th. Peel Hunt restated a “buy” rating and set a GBX 550 ($7.46) price target on shares of Synthomer in a research note on Thursday, January 4th. Berenberg Bank lifted their target price on shares of Synthomer from GBX 525 ($7.12) to GBX 570 ($7.73) and gave the company a “buy” rating in a research note on Monday, November 6th. Finally, Credit Suisse Group reiterated an “underperform” rating and issued a GBX 390 ($5.29) target price on shares of Synthomer in a research note on Tuesday, November 7th.
Synthomer (SYNT) opened at GBX 489.80 ($6.64) on Tuesday. The company has a market cap of $1,660.00 and a PE ratio of 1,580.00. Synthomer has a one year low of GBX 370 ($5.02) and a one year high of GBX 516.37 ($7.00).
Synthomer Company Profile
Synthomer Plc is a specialty chemical company. The Company supplies aqueous polymers in various markets, including paper, carpet and foam, construction and coating, functional polymers, health and protection, specialties and other. It operates in segments, including Europe and North America and Asia and Rest of World.
Receive News & Ratings for Synthomer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synthomer and related companies with MarketBeat.com's FREE daily email newsletter.